by Five Rivers Rx | Mar 11, 2021 | Industry News, Regulations
When initially signed by President Obama in 2013, industry was well aware of the sweeping changes it would cause in the supply chain. With full implementation officially less than three years away, industry has taken huge strides in the implementation of the law – and...
by Five Rivers Rx | Dec 17, 2020 | Industry News
Last month, Iowa became the second of five states to formally recognize/approve the NCDQS QAS Accreditation program, and the first state to approve the program by rule, revising Iowa Code section 17A.8(6). The Maryland Board of Pharmacy approved the NCDQS QAS...
by Five Rivers Rx | Nov 19, 2020 | Industry News
The headwinds for retail pharmacy continue to grow as new technology and services are poised to disrupt the dispensing of pharmaceuticals; and COVID-19 is accelerating the developments. Evolution of Pharmacy In just the past year, there have been various major...
by Five Rivers Rx | Nov 5, 2020 | Industry News, Puerto Rico
Five Rivers RX is making public comments on the Puerto Rico Department of Health’s proposed regulation Number 156B titled For the Operation of Establishments that Manufacture, Distribute, and Dispatch Medications in Puerto Rico. Five Rivers RX supports the aim of...
by Five Rivers Rx | Oct 22, 2020 | Industry News, Uncategorized
The Maryland Board of Pharmacy became the 4th state to accept NCDQS QAS Accreditation or Inspection program as part of their licensing requirement as of their October 21, 2020 meeting. Maryland The Maryland Board of Pharmacy has required out-of-state applicants to...
by Five Rivers Rx | Sep 23, 2020 | Industry News
The pharmaceutical supply chain industry is now funding New York’s efforts to combat the opioid crisis through two separate mechanisms. Originally New York state legislature passed the Opioid Stewardship Act (OSA) that was designed to collect $100 million per year for...
